Skip to main content
. 2019 Jul 4;14:1441–1453. doi: 10.2147/COPD.S195852

Figure 4.

Figure 4

Patient satisfaction with (A) tiotropium/olodaterol treatment, (B) inhaling from the Respimat® device, and (C) handling the Respimat® inhalation device.